Table_2_A Partial Picture of the Single-Cell Transcriptomics of Human IgA Nephropathy.xlsx (9.83 kB)
Download file

Table_2_A Partial Picture of the Single-Cell Transcriptomics of Human IgA Nephropathy.xlsx

Download (9.83 kB)
dataset
posted on 16.04.2021, 05:11 by Rong Tang, Ting Meng, Wei Lin, Chanjuan Shen, Joshua D. Ooi, Peter J. Eggenhuizen, Peng Jin, Xiang Ding, Jinbiao Chen, Yangshuo Tang, Zhou Xiao, Xiang Ao, Weisheng Peng, Qiaoling Zhou, Ping Xiao, Yong Zhong, Xiangcheng Xiao

The molecular mechanisms underlying renal damage of IgA nephropathy (IgAN) remain incompletely defined. Here, single-cell RNA sequencing (scRNA-seq) was applied to kidney biopsies from IgAN and control subjects to define the transcriptomic landscape at single-cell resolution. We presented a comprehensive scRNA-seq analysis of human renal biopsies from IgAN. We showed for the first time that IgAN mesangial cells displayed increased expression of several novel genes including MALAT1, GADD45B, SOX4, and EDIL3, which were related to cell proliferation and matrix accumulation. The overexpressed genes in tubule cells of IgAN were mainly enriched in inflammatory pathways including TNF signaling, IL-17 signaling, and NOD-like receptor signaling. Furthermore, we compared the results of 4 IgAN patients with the published scRNA-Seq data of healthy kidney tissues of three human donors in order to further validate the findings in our study. The results also verified that the overexpressed genes in tubule cells from IgAN patients were mainly enriched in inflammatory pathways including TNF signaling, IL-17 signaling, and NOD-like receptor signaling. The receptor-ligand crosstalk analysis revealed potential interactions between mesangial cells and other cells in IgAN. IgAN patients with overt proteinuria displayed elevated genes participating in several signaling pathways compared with microproteinuria group. It needs to be mentioned that based on number of mesangial cells and other kidney cells analyzed in this study, the results of our study are preliminary and needs to be confirmed on larger number of cells from larger number of patients and controls in future studies. Therefore, these results offer new insight into pathogenesis and identify new therapeutic targets for IgAN.

History

References